Audi ditches its 4-ringed logo, L’eggs gets a leg up, and ‘Nosferatu’ is a perfume now
Here’s the branding news we’re tracking this week. This week in branding news, Audi revealed a new logo, the hosiery brand ...
Monthly Prescribing Reference10d
Drugs in the Pipeline
IGA score of cleared (0) or minimal disease (1) was achieved by a significantly greater proportion of those in the guselkumab vs placebo group, 74.2% vs 12.4%, respectively. Arexvy is currently ...
Mena FN14d
Clover Announces Positive Clinical Data For RSV Vaccine Candidate SCB-1019 Compared Head-To-Head Versus GSK's AREXVY
RSV Neutralizing Antibodies (nAbs): Non-adjuvanted SCB-1019 induced geometric mean titers (GMTs) in RSV-A and RSV-B nAbs that were comparable to AS01E-adjuvanted AREXVY at Day 28, with no ...
Vietnam Investment Reviev14d
I-Mab to Participate at the Truist Securities BioPharma Symposium
I-Mab, a US-based, global, biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that management will ...
Vietnam Investment Reviev14d
Synechron Acquires Cloobees, a global Salesforce summit partner
Synechron, Inc., a leading global digital transformation consulting firm, announced today that it has acquired Cloobees, an award winning, top-tier Salesforce implementation partner. Cloobees will add ...
MarketWatch14d
GSK Net Profit Expected to Rise, Turnover to Fall -- Earnings Preview
WHAT TO WATCH --VACCINES: Investors' concerns linger over sales expectations for the company's respiratory syncytial virus vaccine Arexvy and its best-selling shingles vaccine Shingrix for the ...
PipelineReview.com14d
Vaxxas Licenses Next-Generation Vaccine for Respiratory Syncytial Virus (RSV) from the United States National Institutes of Health (NIH)
The 2023 approval of the world’s first RSV vaccines in the US and Europe, GSK’s AREXVY and Pfizer’s ABRYSVO, was a significant milestone in addressing the grave unmet medical needs associated with RSV ...
Eagle-Tribune14d
Vaxxas Licenses Next-Generation Vaccine for Respiratory Syncytial Virus (RSV) from the United States National Institutes of Health (NIH)
The 2023 approval of the world's first RSV vaccines in the US and Europe, GSK’s AREXVY and Pfizer’s ABRYSVO ... As such, Vaxxas makes no claim that the vaccines are reliable, durable ...
Ontario News14d
Free Flu Shot and New COVID-19 Vaccines Now Available Across Ontario
We are pleased that AREXVY remains among the vaccines being offered this season, and that older Ontarians will continue to benefit from the protection offered by RSV vaccines." "As a company invested ...
pulmonologyadvisor14d
Arexvy Looks Promising for RSV Protection in Younger At-Risk and Immunocompromised Adults
Preliminary data were announced from 2 clinical trials evaluating Arexvy (respiratory syncytial virus [RSV] vaccine, adjuvanted) in a broader population of adults at increased for RSV disease. Arexvy ...
Seeking Alpha16d
GSK Q3 Earnings Preview: Shingrix And Arexvy Make The Stock A 'Strong Buy'
GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress ... Yet, those settlements carry no admission of liability. GSK also has agreed to a qui tam Valisure’s complaint.
Pharmabiz17d
New data for Arexvy, GSK’s RSV vaccine, show potential to help protect a broader group of adults at increased risk for RSV disease
GSK plc announced new preliminary data for Arexvy (respiratory syncytial virus vaccine ... risk in a number of countries including the US and Europe. There are currently no RSV vaccines recommended ...